Calliditas Therapeutics AB (publ) (CALT)
Sep 20, 2024 - CALT was voluntarily delisted
40.00
-0.04 (-0.10%)
Inactive · Last trade price
on Sep 20, 2024
CALT Employees
Calliditas Therapeutics AB had 217 employees as of December 31, 2023. The number of employees increased by 39 or 21.91% compared to the previous year.
Employees
217
Change (1Y)
39
Growth (1Y)
21.91%
Revenue / Employee
$696,277
Profits / Employee
-$208,857
Market Cap
1.10B
Employees Chart
CALT News
- 3 months ago - Delisting of Calliditas Therapeutics AB (publ) from Nasdaq Stockholm - PRNewsWire
- 4 months ago - Notice of extraordinary meeting of Calliditas Therapeutics AB (publ) - PRNewsWire
- 4 months ago - Calliditas Therapeutics takes certain corporate actions following announcement by Asahi Kasei - PRNewsWire
- 4 months ago - Calliditas Therapeutics AB (publ) (CALT) Q2 2024 Earnings Call Transcript - Seeking Alpha
- 4 months ago - Calliditas Interim Report January to June 2024 - PRNewsWire
- 5 months ago - Number of shares and votes in Calliditas Therapeutics - PRNewsWire
- 5 months ago - SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ATRI, CALT on Behalf of Shareholders - Accesswire
- 5 months ago - Calliditas partner STADA receives European Commission decision for full approval of Kinpeygo® for the treatment of IgA Nephropathy - PRNewsWire